MedTrace Logo

The Bicuspid Aortic Stenosis Following Transcatheter Aortic Valve Replacement Registry

NCT02394184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2019-12-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical outcomes of transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve stenosis.

Conditions

Interventions

PROCEDURE

transcatheter aortic valve replacement

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER

  • Seung-Jung Park

    lead OTHER

Principal Investigators

  • Seung-jung Park, MD, PhD · Division of Cardiology, Department of Medicine, Heart Institute, Asan Medical Center, University of Ulsan College of Medicine

  • Gerald Yong, MD · Perth Cardiovascular Institute, Royal Perth Hospital 197 Wellington Street, Perth WA 6000, Australia

  • Edgar Tay, MD · Department of Cardiology, National University Hospital Singapore, 5 Lower Kent Ridge Road, Singapore 119074, Singapore

  • Fabian Nietlispach, MD, PhD · Department of Cardiology, University Heart Center, Raemistrasse 100, CH-8091 Zurich, Switzerland

  • Corrado Tamburino, MD · Division of Cardiology, Ferrarotto Hospital, University of Catania; ETNA Foundation Via Citelli 6, 95124, Catania, Italy

  • Thierry Lefèvre, MD · Institut Hospitalier Jacques Cartier, 6 avenue du Noyer Lambert, FR-91300 Massy, France

  • Marie-Claude Morice, MD · Institut Hospitalier Jacques Cartier, 6 avenue du Noyer Lambert, FR-91300 Massy, France

  • Jeroen J. Bax, MD, PhD · Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands

  • John G. Webb, MD · St. Paul's Hospital, University of British Columbia, 1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada

  • Susheel Kodali, MD · Herbert and Sandi Feinberg Interventional Cardiology, Heart Valve Center at Columbia University Medical Center/New York-Presbyterian Hospital, 177 Fort Washington Avenue,

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2019-09-24
Completion
2019-09-24

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02394184 on ClinicalTrials.gov